King-Friend Biochemical Pharmaceutical Co. Ltd.
King-Friend Biochemical Pharmaceutical Co. Ltd., commonly referred to as King-Friend, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in 1995, the company has made significant strides in the development and production of high-quality biochemical products, primarily focusing on APIs (Active Pharmaceutical Ingredients) and intermediates. With a strong operational presence across various regions, King-Friend has built a reputation for its innovative solutions in the pharmaceutical sector. The company’s core offerings include a diverse range of pharmaceutical raw materials, which are distinguished by their purity and compliance with international standards. Recognised for its commitment to quality and sustainability, King-Friend has achieved notable milestones, positioning itself as a trusted partner in the global pharmaceutical supply chain. Its dedication to research and development continues to drive its success in an increasingly competitive market.
DitchCarbon Score
How does King-Friend Biochemical Pharmaceutical Co. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
King-Friend Biochemical Pharmaceutical Co. Ltd.'s score of 10 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
King-Friend Biochemical Pharmaceutical Co. Ltd.'s reported carbon emissions
As of the latest available data, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. has not publicly reported any specific carbon emissions figures in kg CO2e. However, the company is committed to addressing climate change through various initiatives. King-Friend Biochemical has made a commitment to near-term climate targets, although specific reduction targets have not been detailed. The company has not yet committed to a net-zero target or specified a timeline for achieving such goals. Operating within the Pharmaceuticals, Biotechnology, and Life Sciences sector in China, King-Friend Biochemical is part of an industry increasingly focused on sustainability and reducing carbon footprints. Their commitment to near-term targets indicates a proactive approach to climate action, aligning with broader industry trends towards enhanced environmental responsibility. While specific emissions data is currently unavailable, the company's commitment to climate initiatives reflects a growing recognition of the importance of sustainability in the pharmaceutical sector.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
King-Friend Biochemical Pharmaceutical Co. Ltd. is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
